Nightly Wearable Monitoring During Home-Based Submental Electrical Stimulation for Obstructive Sleep Apnea
Clinical Testing of a Physiological Signal Detection, Recognition and Feedback System for Obstructive Sleep Apnea: Home-Based Submental Transcutaneous Neuromuscular Electrical Stimulation With Nightly Ring-Type Monitoring
This single-arm pilot study evaluates the feasibility of nightly wearable monitoring with a ring-type sleep monitor during a 4-week home-based program of submental transcutaneous neuromuscular electrical stimulation in adults with obstructive sleep apnea, and describes changes in the ring-derived apnea-hypopnea index, sleep continuity, STOP-Bang score and upper-airway anatomy on CT before and after training.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Kaohsiung City, Taiwan, 82445
- Rekrytointi
- E-Da Hospital
-
Ottaa yhteyttä:
- Chih-Chun Wang
- Puhelinnumero: +886-988-092-216
- Sähköposti: CCW5969@yahoo.com.tw
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Adults aged 20 to 65 years
- Obstructive sleep apnea diagnosed by a physician on polysomnography or an equivalent respiratory-event index test with AHI >= 5 events/h (mild 5-14.9, moderate 15-29.9, severe >= 30)
Exclusion Criteria:
- AHI < 5 events/h
- Pregnancy
- Prior nasal CPAP therapy
- Inflammation, rash, broken skin, swelling or infection at the stimulation site
- Cardiac disease, pacemaker or other implanted electronic or metallic device
- Allergic reaction to the device
- Concurrent use of other wearable medical devices (e.g., insulin pump)
- Cognitive impairment
- Suspected or confirmed epilepsy
- Central pain syndromes including headache
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Hoito
- Jako: Ei käytössä
- Inventiomalli: Yksittäinen ryhmätehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Submental NMES with nightly ring monitoring
Adults with obstructive sleep apnea perform home-based submental transcutaneous neuromuscular electrical stimulation (30 minutes every evening for 28 consecutive nights) and wear a ring-type sleep monitor every night during and after training. |
Submental transcutaneous neuromuscular electrical stimulation with the RS-18 wireless low-frequency stimulator (Jie-Mai Medical Technology; TFDA license 007859; off-label use). Biphasic symmetrical pulses, 250 us, 30-100 Hz program, intensity self-titrated to a strong but comfortable contraction. One 30-minute session every evening before bedtime for 28 consecutive nights at home, after supervised instruction. A ring-type wearable sleep monitor (Belun Ring BLS-100) worn on the finger every night during the 4-week training period to record pulse oximetry, heart rate and accelerometry signals for ring-derived apnea-hypopnea index, oxygen desaturation index and sleep parameters. Used for monitoring only; no therapeutic function. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Ring-Derived Apnea-Hypopnea Index (bAHI3)
Aikaikkuna: Baseline (first 7 nights) and end of training (nights 22-28 or last 7 recordings)
|
Change in the ring-derived apnea-hypopnea index (bAHI3, events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 nightly recordings with the mean of the last 7 nightly recordings. |
Baseline (first 7 nights) and end of training (nights 22-28 or last 7 recordings)
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Ring-Derived Apnea-Hypopnea Index Using the 4% Desaturation Criterion (bAHI4)
Aikaikkuna: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived apnea-hypopnea index using the 4% oxygen desaturation criterion (bAHI4, events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Sleep Efficiency
Aikaikkuna: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived sleep efficiency (%, total sleep time divided by total recording time) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in STOP-Bang Score
Aikaikkuna: Baseline and end of 4-week training
|
STOP-Bang questionnaire score (range 0-8; higher scores indicate higher risk of obstructive sleep apnea), before vs after training. |
Baseline and end of 4-week training
|
|
Change in Minimal Nasopharyngeal Cross-Sectional Area on Supine CT
Aikaikkuna: Baseline and end of 4-week training
|
Minimal nasopharyngeal cross-sectional area (mm2) measured on supine computed tomography, before vs after training. |
Baseline and end of 4-week training
|
|
Post-Training Satisfaction Score
Aikaikkuna: End of 4-week training
|
Participant-rated satisfaction with the training program on a 0-100 scale (higher scores indicate greater satisfaction). |
End of 4-week training
|
|
Adherence: Proportion of Nights With a Valid Ring Recording
Aikaikkuna: 4 weeks
|
Number of nights with a valid ring-type monitor recording divided by the number of scheduled nights, expressed as a percentage. |
4 weeks
|
|
Number of Participants With Adverse Events
Aikaikkuna: During the 4-week training and up to 90 days of follow-up
|
Adverse events related to electrical stimulation or ring wear (e.g., skin irritation, pain, discomfort), recorded during training and follow-up. |
During the 4-week training and up to 90 days of follow-up
|
|
Change in Ring-Derived Oxygen Desaturation Index (ODI)
Aikaikkuna: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived oxygen desaturation index (events/h) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Sleep-Onset Latency
Aikaikkuna: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived sleep-onset latency (min) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
|
Change in Ring-Derived Total Sleep Time
Aikaikkuna: Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Ring-derived total sleep time (min) measured by a ring-type sleep monitor (Belun Ring BLS-100), comparing the mean of the first 7 valid nightly recordings with the mean of the last 7 valid nightly recordings. |
Baseline (first 7 valid nights) and end of training (last 7 valid nights), 4 weeks
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- AF10-008
- EMRP37113N (Muu tunniste: Institutional Review Board of E-Da Hospital)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
De-identified nightly data are available from the corresponding author on reasonable request.
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .